Evidence map›Paper›PMID 40269025›Full record

ArticleScientific reports2025

Stability analysis of Rift Valley fever transmission model with efficient and cost-effective interventions.

Samson Olaniyi, Olajumoke D Falowo, Abiodun T Oladipo, Gideon K Gogovi, Adekunle O Sangotola

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Samson OlaniyiDepartment of Pure and Applied Mathematics, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.
Olajumoke D FalowoDepartment of Pure and Applied Mathematics, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.
Abiodun T OladipoDepartment of Pure and Applied Mathematics, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.
Gideon K GogoviDepartment of Biostatistics and Health Data Science, Lehigh University, Bethlehem, PA, USA. gig323@lehigh.edu.
Adekunle O SangotolaDepartment of Physical Sciences, Bells University of Technology, Ota, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rift Valley fever (RVF) is one of the neglected tropical diseases in Africa, likely to spread to other countries outside the continent, and capable of wreaking havoc on livestock and human populations. This study presents a novel mathematical model for RVF, taking into account time-dependent treatment, vaccination, and environmental sanitation controls. The existence of both RVF-free (disease-free) and RVF-present (endemic) equilibrium points are established analytically. Using the center manifold theory, the co-existence of both equilibrium points is characterized via bifurcation analysis. Castillo-Chavez's M-matrix approach and Lyapunov function are used to carry out the global stability analysis of the model around the disease-free and endemic equilibrium points, respectively. Furthermore, existence of triple optimal control is rigorously proved and characterized using Pontryagin's maximum principle. Consequently, the most efficient and cost-effective of each of the controls and several combinations of the controls are investigated through efficiency and cost-effectiveness analyses. The findings of the study provide insights into long term behavior of the RVF dynamics in the population, suggesting efficient prevention and optimal control measures at minimal cost of intervention.

Indexed as

Models, TheoreticalRift Valley FeverAnimalsCost-Benefit AnalysisHumansLivestockRift Valley fever virusVaccinationBifurcation analysisEconomic analysisGlobal stabilityMathematical modelOptimal controlRift Valley fever

Identifiers

PMID40269025
PMCPMC12019165

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.